Literature DB >> 14970200

Regulation of hepatic apolipoprotein B-lipoprotein assembly and secretion by the availability of fatty acids. I. Differential response to the delivery of fatty acids via albumin or remnant-like emulsion particles.

Yuan-Li Zhang1, Antonio Hernandez-Ono, Carol Ko, Koichi Yasunaga, Li-Shin Huang, Henry N Ginsberg.   

Abstract

The in vivo effects of increased delivery of fatty acids (FA) to the liver are poorly defined. Therefore, we compared the effects of infusing either 6 mM oleic acid (OA) bound to albumin, 0.5-20% Intralipid, or saline for 3 or 6 h into male C57BL/6J mice. Infusions were followed by studies of triglyceride (TG) and apoB secretion. Although plasma FA levels increased similarly after either 20% Intralipid or 6 mM OA, TG secretion increased only after infusion of 4-20% Intralipid; TG secretion was unchanged by 6 mM OA. By contrast, 6-h infusions of either 6 mM OA or 4-20% Intralipid increased apoB secretion. 6 mM OA and 20% Intralipid each increased secretion of apoB from primary hepatocytes ex vivo. Importantly, 0.5-2% Intralipid, which delivered more FA to the liver than 6 mM OA, did not stimulate apoB secretion. Hepatic apoB mRNA levels were unaffected by either 6 mM OA or 20% Intralipid, but microsomal triglyceride transfer protein mRNA was significantly lower after 6-h infusions with 6 mM OA versus either saline or 20% Intralipid. Lower microsomal triglyceride transfer protein mRNA levels were associated with reduced hepatic TG mass after 6-h infusions of 6 mM OA. We conclude that 1) increased FA delivery to the liver in vivo increases secretion of apoB-lipoproteins via post-transcriptional mechanisms, 2) OA-induced apoB-lipoprotein secretion occurred at least in part via mechanisms other than by providing substrate for TG synthesis, and 3) the route of delivery of FA is important for its effects on apoB secretion.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14970200     DOI: 10.1074/jbc.M400220200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  Apolipoprotein B100 secretion by cultured ARPE-19 cells is modulated by alteration of cholesterol levels.

Authors:  Tinghuai Wu; Masashi Fujihara; Jane Tian; Miroslava Jovanovic; Celene Grayson; Marisol Cano; Peter Gehlbach; Philippe Margaron; James T Handa
Journal:  J Neurochem       Date:  2010-07-27       Impact factor: 5.372

Review 2.  Increased very low density lipoprotein (VLDL) secretion, hepatic steatosis, and insulin resistance.

Authors:  Sung Hee Choi; Henry N Ginsberg
Journal:  Trends Endocrinol Metab       Date:  2011-05-26       Impact factor: 12.015

Review 3.  Treatment of Dyslipidemias to Prevent Cardiovascular Disease in Patients with Type 2 Diabetes.

Authors:  Maryam Khavandi; Francisco Duarte; Henry N Ginsberg; Gissette Reyes-Soffer
Journal:  Curr Cardiol Rep       Date:  2017-01       Impact factor: 2.931

4.  Low density lipoprotein delays clearance of triglyceride-rich lipoprotein by human subcutaneous adipose tissue.

Authors:  Simon Bissonnette; Huda Salem; Hanny Wassef; Nathalie Saint-Pierre; Annie Tardif; Alexis Baass; Robert Dufour; May Faraj
Journal:  J Lipid Res       Date:  2013-02-17       Impact factor: 5.922

Review 5.  Pathogenesis and pathophysiology of the cardiometabolic syndrome.

Authors:  Erik P Kirk; Samuel Klein
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-12       Impact factor: 3.738

6.  Different fatty acids inhibit apoB100 secretion by different pathways: unique roles for ER stress, ceramide, and autophagy.

Authors:  Jorge Matias Caviglia; Constance Gayet; Tsuguhito Ota; Antonio Hernandez-Ono; Donna M Conlon; Hongfeng Jiang; Edward A Fisher; Henry N Ginsberg
Journal:  J Lipid Res       Date:  2011-06-30       Impact factor: 5.922

7.  Impaired fasting glucose and impaired glucose tolerance have distinct lipoprotein and apolipoprotein changes: the insulin resistance atherosclerosis study.

Authors:  Carlos Lorenzo; Sara Hartnett; Anthony J Hanley; Marian J Rewers; Lynne E Wagenknecht; Andrew J Karter; Steven M Haffner
Journal:  J Clin Endocrinol Metab       Date:  2013-02-28       Impact factor: 5.958

Review 8.  The ever-expanding role of degradation in the regulation of apolipoprotein B metabolism.

Authors:  Henry N Ginsberg; Edward A Fisher
Journal:  J Lipid Res       Date:  2008-12-02       Impact factor: 5.922

9.  Both intestinal and hepatic lipoprotein production are stimulated by an acute elevation of plasma free fatty acids in humans.

Authors:  Hélène Duez; Benoît Lamarche; René Valéro; Mirjana Pavlic; Spencer Proctor; Changting Xiao; Linda Szeto; Bruce W Patterson; Gary F Lewis
Journal:  Circulation       Date:  2008-04-28       Impact factor: 29.690

10.  Inhibition of apolipoprotein B100 secretion by lipid-induced hepatic endoplasmic reticulum stress in rodents.

Authors:  Tsuguhito Ota; Constance Gayet; Henry N Ginsberg
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.